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We would like to thank Dr Apostolakis for his valuable
comment on our recently published results on procalcitonin
(PCT) in the postoperative course after decortication in case
of pleural empyema [1,2].
The point of the study was the observation of the
postoperative course of PCT in comparison to CrP. We
registered that PCT seems ‘to reflect the postoperative
clinical course more accurately than CrP’ and has had ‘a good
correlation with the postoperative course in case of SIRS or
sepsis’ [2].On theotherhand lowpreoperative levels ofPCT, as
was the case in two patients (9.1%), do not exclude a localized
(without systemic signs) infection. The patient with the
postoperative recurrent pleural effusions showed a preopera-
tive level of 0.35 ng/ml. This is not a low level but rather a sign
of an infection, yet not necessarily a systemic one (serum or
plasma PCT concentrations of healthy persons are measured
with the Kryptor-assay are below 0.06 ng/ml [3]).
If there was only the sneaking suspicion that a pleural
empyema was due to tuberculosis (clinic, anamnesis) this
patient was excluded from the trial from the beginning of
treatment. So not one of the patients in the presented study
had tuberculosis.
We are sure that in case of an earlier availability of the
PCT values most of the patients with an antibiotic treatment
after discharge would not have received antibiotics (up to
85.7%). ‘So the use of PCT instead of CrP in the postoperative
course after decortication could save at least 7 days of
antibiotic treatment’ [2]. This is in accordance with other
trials [4,5].
Indeed, the number of patients is small, in this
prospective, but not randomized trial. And it is known that
PCT levels show a wide variation but: ‘In general dynamics of
PCT levels, rather than the absolute values, may be more
important for identifying patients with persistent infection or
infectious complications after surgery’ [2].
Therefore we also think it is very important to have
randomized studies with more patients, maybe in a multi-
center trial. These studies should determine the value of PCT
as a promising marker in thoracic surgery not only after
decortication in case of pleural empyema.
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We readwith great interest the article by Dreyfus et al. on
tricuspid leaflet augmentation in functional tricuspid
regurgitation [1]. We congratulate the authors for their
innovative approach to relieve tethering-induced functional
tricuspid regurgitation and their excellent results. As
mentioned by the authors, inadequate tricuspid leaflet
coaptation has been shown to arise from annulus dilatation
greater than 40 mm and tethering of the valve leaflets in
functional tricuspid regurgitation. Annuloplasty addresses
annular dilatation, however it has not been shown to
improve leaflet tethering. Several authors have proposed
valve repair techniques to address severe tethering, such as
a tricuspid version of the Alfieri repair or ‘clover’ technique
[2] or right ventricular remodeling [3]. The method
described by Dreyfus et al. is innovative, in that it is the
first to increase leafletmobility and coaptation in the dilated
right ventricle. However, paraphrasing the author’s own
remarks on functionalmitral regurgitation repair at the 22nd
EACTS meeting, this remains a valvular approach to a
ventricular problem. Furthermore, Park et al. recently
showed in a real-time 3D echocardiographic study of 54
patients with functional tricuspid regurgitation [4] that
tethering was predominantly due to the septal leaflet, and
not the anterior leaflet. These results are counter-intuitive,
